Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation

Diminished neo-antigen response to keyhole limpet hemocyanin (KLH) vaccines in patients after treatment with chemotherapy or hematopoietic cell transplantation

Relapse is the most common cause of treatment failure for advanced cancer, even those treated with autologous hematopoietic cell transplantation (HCT). Effective tumor-specific immunotherapy may decrease relapse, however, this will fail if the immune system is unable to respond. We developed a strat...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Clinical immunology (Orlando, Fla.). - 1999. - 117(2005), 2 vom: 05. Nov., Seite 144-51
1. Verfasser: Miller, Jeffrey S (VerfasserIn)
Weitere Verfasser: Curtsinger, Julie, Berthold, Melinda, Malvey, Kirsten, Bliss, Robin L, Le, Chap T, Fautsch, Susan K, Dudek, Arkadiusz Z, Blazar, Bruce R, Panoskaltsis-Mortari, Angela
Format: Aufsatz
Sprache:English
Veröffentlicht: 2005
Zugriff auf das übergeordnete Werk:Clinical immunology (Orlando, Fla.)
Schlagworte:Comparative Study Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, P.H.S. Biomarkers Cancer Vaccines Immunoglobulins Hemocyanins 9013-72-3 keyhole-limpet hemocyanin FV4Y0JO2CX